{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:21:34Z","timestamp":1769595694894,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12967-015-0599-5","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T11:24:44Z","timestamp":1437477884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation"],"prefix":"10.1186","volume":"13","author":[{"given":"Bala Sai","family":"Sundarasetty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Kloess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Oberschmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Naundorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Kuehlcke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anusara","family":"Daenthanasanmak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Gerasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constanca","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Blasczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Fronza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof","family":"von Kalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rothe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold","family":"Ganser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Koehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Stripecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,22]]},"reference":[{"issue":"31","key":"599_CR1","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1200\/JCO.2013.50.2567","volume":"31","author":"R Mawad","year":"2013","unstructured":"Mawad R, Gooley TA, Sandhu V, Lionberger J, Scott B, Sandmaier BM et al (2013) Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission. J Clin Oncol 31(31):3883\u20133888. doi: 10.1200\/JCO.2013.50.2567","journal-title":"J Clin Oncol"},{"issue":"25","key":"599_CR2","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1182\/blood-2011-02-334623","volume":"117","author":"W Krenger","year":"2011","unstructured":"Krenger W, Blazar BR, Hollander GA (2011) Thymic T-cell development in allogeneic stem cell transplantation. Blood 117(25):6768\u20136776. doi: 10.1182\/blood-2011-02-334623","journal-title":"Blood"},{"issue":"23","key":"599_CR3","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1182\/blood-2008-10-143560","volume":"113","author":"M Boeckh","year":"2009","unstructured":"Boeckh M, Ljungman P (2009) How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 113(23):5711\u20135719. doi: 10.1182\/blood-2008-10-143560","journal-title":"Blood"},{"issue":"1","key":"599_CR4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcmd.2007.07.002","volume":"40","author":"H Einsele","year":"2008","unstructured":"Einsele H, Kapp M, Grigoleit GU (2008) CMV-specific T cell therapy. Blood Cells Mol Dis 40(1):71\u201375. doi: 10.1016\/j.bcmd.2007.07.002","journal-title":"Blood Cells Mol Dis"},{"issue":"11","key":"599_CR5","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1586\/erv.10.125","volume":"9","author":"H Sung","year":"2010","unstructured":"Sung H, Schleiss MR (2010) Update on the current status of cytomegalovirus vaccines. Expert Rev Vaccines 9(11):1303\u20131314. doi: 10.1586\/erv.10.125","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"599_CR6","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1158\/1078-0432.CCR-08-2729","volume":"15","author":"P Verdijk","year":"2009","unstructured":"Verdijk P, Aarntzen EH, Lesterhuis WJ, Boullart AC, Kok E, van Rossum MM et al (2009) Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients. Clin Cancer Res 15(7):2531\u20132540. doi: 10.1158\/1078-0432.CCR-08-2729","journal-title":"Clin Cancer Res"},{"issue":"9","key":"599_CR7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nri2379","volume":"8","author":"P Bousso","year":"2008","unstructured":"Bousso P (2008) T-cell activation by dendritic cells in the lymph node: lessons from the movies. Nat Rev Immunol 8(9):675\u2013684. doi: 10.1038\/nri2379","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"599_CR8","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.3324\/haematol.11076","volume":"92","author":"C Talarn","year":"2007","unstructured":"Talarn C, Urbano-Ispizua A, Martino R, Perez-Simon JA, Batlle M, Herrera C et al (2007) Kinetics of recovery of dendritic cell subsets after reduced-intensity conditioning allogeneic stem cell transplantation and clinical outcome. Haematologica 92(12):1655\u20131663. doi: 10.3324\/haematol.11076","journal-title":"Haematologica"},{"issue":"1","key":"599_CR9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2141.2002.03798.x","volume":"119","author":"U Grigoleit","year":"2002","unstructured":"Grigoleit U, Riegler S, Einsele H, Laib Sampaio K, Jahn G, Hebart H et al (2002) Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocyte-derived immature dendritic cells. Br J Haematol 119(1):189\u2013198","journal-title":"Br J Haematol"},{"issue":"7","key":"599_CR10","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3109\/14653241003587645","volume":"12","author":"T Feuchtinger","year":"2010","unstructured":"Feuchtinger T, Opherk K, Bicanic O, Schumm M, Grigoleit GU, Hamprecht K et al (2010) Dendritic cell vaccination in an allogeneic stem cell recipient receiving a transplant from a human cytomegalovirus (HCMV)-seronegative donor: induction of a HCMV-specific T(helper) cell response. Cytotherapy 12(7):945\u2013950. doi: 10.3109\/14653241003587645","journal-title":"Cytotherapy"},{"issue":"5","key":"599_CR11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1086\/520538","volume":"196","author":"GU Grigoleit","year":"2007","unstructured":"Grigoleit GU, Kapp M, Hebart H, Fick K, Beck R, Jahn G et al (2007) Dendritic cell vaccination in allogeneic stem cell recipients: induction of human cytomegalovirus (HCMV)-specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donor. J Infect Dis 196(5):699\u2013704. doi: 10.1086\/520538","journal-title":"J Infect Dis"},{"issue":"7","key":"599_CR12","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4161\/onci.21494","volume":"1","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Senovilla L, Vacchelli E, Eggermont A, Fridman WH, Galon J et al (2012) Trial watch: dendritic cell-based interventions for cancer therapy. Oncoimmunology 1(7):1111\u20131134. doi: 10.4161\/onci.21494","journal-title":"Oncoimmunology"},{"issue":"5","key":"599_CR13","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/sj.mt.6300166","volume":"15","author":"RG Carroll","year":"2007","unstructured":"Carroll RG, June CH (2007) Programming the next generation of dendritic cells. Mol Ther 15(5):846\u2013848. doi: 10.1038\/sj.mt.6300166","journal-title":"Mol Ther"},{"issue":"1\u20132","key":"599_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2013.05.007","volume":"176","author":"T Liechtenstein","year":"2013","unstructured":"Liechtenstein T, Perez-Janices N, Bricogne C, Lanna A, Dufait I, Goyvaerts C et al (2013) Immune modulation by genetic modification of dendritic cells with lentiviral vectors. Virus Res 176(1\u20132):1\u201315. doi: 10.1016\/j.virusres.2013.05.007","journal-title":"Virus Res"},{"issue":"3","key":"599_CR15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1586\/erv.10.9","volume":"9","author":"M Pincha","year":"2010","unstructured":"Pincha M, Sundarasetty BS, Stripecke R (2010) Lentiviral vectors for immunization: an inflammatory field. Expert Rev Vaccines 9(3):309\u2013321. doi: 10.1586\/erv.10.9","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"599_CR16","doi-asserted-by":"crossref","first-page":"e48644","DOI":"10.1371\/journal.pone.0048644","volume":"7","author":"F Coutant","year":"2012","unstructured":"Coutant F, Sanchez David RY, Felix T, Boulay A, Caleechurn L, Souque P et al (2012) A nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malaria. PLoS One 7(11):e48644. doi: 10.1371\/journal.pone.0048644","journal-title":"PLoS One"},{"issue":"7","key":"599_CR17","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1128\/JVI.02519-08","volume":"83","author":"K Karwacz","year":"2009","unstructured":"Karwacz K, Mukherjee S, Apolonia L, Blundell MP, Bouma G, Escors D et al (2009) Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapy. J Virol 83(7):3094\u20133103. doi: 10.1128\/JVI.02519-08","journal-title":"J Virol"},{"issue":"9","key":"599_CR18","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/sj.mt.6300241","volume":"15","author":"DR Negri","year":"2007","unstructured":"Negri DR, Michelini Z, Baroncelli S, Spada M, Vendetti S, Buffa V et al (2007) Successful immunization with a single injection of non-integrating lentiviral vector. Mol Ther 15(9):1716\u20131723. doi: 10.1038\/sj.mt.6300241","journal-title":"Mol Ther"},{"key":"599_CR19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/biomedicines2010014","volume":"2","author":"A Shaw","year":"2014","unstructured":"Shaw A, Cornetta K (2014) Design and potential of non-integrating lentiviral vectors. Biomedicines 2:14\u201335","journal-title":"Biomedicines"},{"issue":"34","key":"599_CR20","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1016\/j.vaccine.2012.05.063","volume":"30","author":"A Daenthanasanmak","year":"2012","unstructured":"Daenthanasanmak A, Salguero G, Borchers S, Figueiredo C, Jacobs R, Sundarasetty BS et al (2012) Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo. Vaccine 30(34):5118\u20135131. doi: 10.1016\/j.vaccine.2012.05.063","journal-title":"Vaccine"},{"issue":"10","key":"599_CR21","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1089\/hum.2010.215","volume":"22","author":"G Salguero","year":"2011","unstructured":"Salguero G, Sundarasetty BS, Borchers S, Wedekind D, Eiz-Vesper B, Velaga S et al (2011) Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1\u2212\/\u2212.IL-2rgammac\u2212\/\u2212 mice. Hum Gene Ther 22(10):1209\u20131224. doi: 10.1089\/hum.2010.215","journal-title":"Hum Gene Ther"},{"key":"599_CR22","author":"G Salguero","year":"2014","unstructured":"Salguero G, Daenthanasanmak A, Munz C, Raykova A, Guzman CA, Riese P et al (2014) Dendritic cell-mediated immune humanization of mice: implications for allogeneic and xenogeneic stem cell transplantation. J Immunol. doi: 10.4049\/jimmunol.1302887","journal-title":"J Immunol"},{"key":"599_CR23","doi-asserted-by":"crossref","first-page":"14060","DOI":"10.1038\/mtm.2014.60","volume":"1","author":"A Daenthanasanmak","year":"2014","unstructured":"Daenthanasanmak A, Salguero G, Sundarasetty BS, Waskow C, Cosgun KN, Guzman CA et al (2014) Engineered dendritic cells from cord blood and adult blood accelerate effector T cell immune reconstitution against HCMV. Mol Ther Methods Clin Dev 1:14060. doi: 10.1038\/mtm.2014.60 (published online 7 January 2015)","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"599_CR24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jviromet.2013.06.014","volume":"193","author":"Y Badralmaa","year":"2013","unstructured":"Badralmaa Y, Natarajan V (2013) Impact of the DNA extraction method on 2-LTR DNA circle recovery from HIV-1 infected cells. J Virol Methods 193(1):184\u2013189. doi: 10.1016\/j.jviromet.2013.06.014","journal-title":"J Virol Methods"},{"issue":"4","key":"599_CR25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/gt.2011.117","volume":"19","author":"M Rothe","year":"2012","unstructured":"Rothe M, Rittelmeyer I, Iken M, Rudrich U, Schambach A, Glage S et al (2012) Epidermal growth factor improves lentivirus vector gene transfer into primary mouse hepatocytes. Gene Ther 19(4):425\u2013434. doi: 10.1038\/gt.2011.117","journal-title":"Gene Ther"},{"issue":"12","key":"599_CR26","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nmeth1103","volume":"4","author":"M Schmidt","year":"2007","unstructured":"Schmidt M, Schwarzwaelder K, Bartholomae C, Zaoui K, Ball C, Pilz I et al (2007) High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). Nat Methods 4(12):1051\u20131057. doi: 10.1038\/nmeth1103","journal-title":"Nat Methods"},{"issue":"1","key":"599_CR27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/exd.12581","volume":"24","author":"M Nieda","year":"2015","unstructured":"Nieda M, Terunuma H, Eiraku Y, Deng X, Nicol AJ (2015) Effective induction of melanoma-antigen-specific CD8+ T cells via Vgamma9gammadeltaT cell expansion by CD56(high+) Interferon-alpha-induced dendritic cells. Exp Dermatol 24(1):35\u201341. doi: 10.1111\/exd.12581","journal-title":"Exp Dermatol"},{"issue":"4","key":"599_CR28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","volume":"13","author":"L Chen","year":"2013","unstructured":"Chen L, Flies DB (2013) Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 13(4):227\u2013242. doi: 10.1038\/nri3405","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"599_CR29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1089\/hgtb.2011.170","volume":"23","author":"M Pincha","year":"2012","unstructured":"Pincha M, Sundarasetty BS, Salguero G, Gutzmer R, Garritsen H, Macke L et al (2012) Identity, potency, in vivo viability, and scaling up production of lentiviral vector-induced dendritic cells for melanoma immunotherapy. Hum Gene Ther Method 23(1):38\u201355. doi: 10.1089\/hgtb.2011.170","journal-title":"Hum Gene Ther Method"},{"issue":"5","key":"599_CR30","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/hep.24230","volume":"53","author":"J Matrai","year":"2011","unstructured":"Matrai J, Cantore A, Bartholomae CC, Annoni A, Wang W, Acosta-Sanchez A et al (2011) Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk. Hepatology 53(5):1696\u20131707. doi: 10.1002\/hep.24230","journal-title":"Hepatology"},{"issue":"6","key":"599_CR31","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1371\/journal.pone.0000570","volume":"2","author":"U Abel","year":"2007","unstructured":"Abel U, Deichmann A, Bartholomae C, Schwarzwaelder K, Glimm H, Howe S et al (2007) Real-time definition of non-randomness in the distribution of genomic events. PLoS One 2(6):e570. doi: 10.1371\/journal.pone.0000570","journal-title":"PLoS One"},{"key":"599_CR32","doi-asserted-by":"crossref","unstructured":"Akagi K, Suzuki T, Stephens RM, Jenkins NA, Copeland NG (2004) RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res 32(Database issue):D523\u2013D527. doi: 10.1093\/nar\/gkh013","DOI":"10.1093\/nar\/gkh013"},{"issue":"12","key":"599_CR33","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1371\/journal.pcbi.0020166","volume":"2","author":"J Ridder de","year":"2006","unstructured":"de Ridder J, Uren A, Kool J, Reinders M, Wessels L (2006) Detecting statistically significant common insertion sites in retroviral insertional mutagenesis screens. PLoS Comput Biol 2(12):e166. doi: 10.1371\/journal.pcbi.0020166","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"599_CR34","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/blood-2007-01-068759","volume":"110","author":"C Cattoglio","year":"2007","unstructured":"Cattoglio C, Facchini G, Sartori D, Antonelli A, Miccio A, Cassani B et al (2007) Hot spots of retroviral integration in human CD34+ hematopoietic cells. Blood 110(6):1770\u20131778. doi: 10.1182\/blood-2007-01-068759","journal-title":"Blood"},{"issue":"6148","key":"599_CR35","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","volume":"341","author":"A Biffi","year":"2013","unstructured":"Biffi A, Montini E, Lorioli L, Cesani M, Fumagalli F, Plati T et al (2013) Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 341(6148):1233158. doi: 10.1126\/science.1233158","journal-title":"Science"},{"issue":"3","key":"599_CR36","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/hum.2010.060","volume":"22","author":"OW Merten","year":"2011","unstructured":"Merten OW, Charrier S, Laroudie N, Fauchille S, Dugue C, Jenny C et al (2011) Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application. Hum Gene Ther 22(3):343\u2013356. doi: 10.1089\/hum.2010.060","journal-title":"Hum Gene Ther"},{"issue":"6148","key":"599_CR37","doi-asserted-by":"crossref","first-page":"1233151","DOI":"10.1126\/science.1233151","volume":"341","author":"A Aiuti","year":"2013","unstructured":"Aiuti A, Biasco L, Scaramuzza S, Ferrua F, Cicalese MP, Baricordi C et al (2013) Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott\u2013Aldrich syndrome. Science 341(6148):1233151. doi: 10.1126\/science.1233151","journal-title":"Science"},{"issue":"16","key":"599_CR38","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","volume":"368","author":"SA Grupp","year":"2013","unstructured":"Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR et al (2013) Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. New Engl J Med 368(16):1509\u20131518. doi: 10.1056\/NEJMoa1215134","journal-title":"New Engl J Med"},{"key":"599_CR39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.7150\/jca.2.331","volume":"2","author":"DL Porter","year":"2011","unstructured":"Porter DL, Kalos M, Zheng Z, Levine B, June C (2011) Chimeric antigen receptor therapy for B-cell malignancies. J Cancer 2:331\u2013332","journal-title":"J Cancer"},{"issue":"2","key":"599_CR40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ymthe.2006.03.012","volume":"14","author":"SD Barr","year":"2006","unstructured":"Barr SD, Ciuffi A, Leipzig J, Shinn P, Ecker JR, Bushman FD (2006) HIV integration site selection: targeting in macrophages and the effects of different routes of viral entry. Mol Ther 14(2):218\u2013225. doi: 10.1016\/j.ymthe.2006.03.012","journal-title":"Mol Ther"},{"issue":"4","key":"599_CR41","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/mt.2011.19","volume":"19","author":"CC Bartholomae","year":"2011","unstructured":"Bartholomae CC, Arens A, Balaggan KS, Yanez-Munoz RJ, Montini E, Howe SJ et al (2011) Lentiviral vector integration profiles differ in rodent postmitotic tissues. Mol Ther 19(4):703\u2013710. doi: 10.1038\/mt.2011.19","journal-title":"Mol Ther"},{"issue":"1","key":"599_CR42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/hum.2005.16.17","volume":"16","author":"P Manilla","year":"2005","unstructured":"Manilla P, Rebello T, Afable C, Lu X, Slepushkin V, Humeau LM et al (2005) Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector. Hum Gene Ther 16(1):17\u201325. doi: 10.1089\/hum.2005.16.17","journal-title":"Hum Gene Ther"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-015-0599-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T12:05:59Z","timestamp":1498219559000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.translational-medicine.com\/content\/13\/1\/240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,22]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1186\/s12967-015-0599-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,22]]},"article-number":"240"}}